Received Jun 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
Patient received the first dose at age 15 and then forgot about completing the series.; No additional AE; This spontaneous report was received from a health care professional referring to a 25-year-old male patient. Information regarding the patient's concurrent conditions, medical history, or concomitant medications was not provided. On an unknown date, reported as when the patient was 15-year-old, he received the first dose of Human papillomavirus 9-valent vaccine recombinant suspension for injection (GARDASIL 9) as a dose of 0.5 ml administered for prophylaxis (route of administration, anatomical location, lot number, and expiration date were not reported), the patient forgot about completing the vaccine series. (Inappropriate schedule of product administration). There was not adverse event reported.